It reduced the phosphorylation of the downstream signaling pathway mediators STAT5 and ERK and induced cell cycle arrest in the sub-G1 phase and apoptosis, while displaying a very low activity on FLT3-wt AML cells and other cancer cell lines. Here, STAT5A is linked to acute myeloid leukemia.